Iridium complex, method for manufacturing same, and organic light-emitting devices using same

Abstract

An iridium complex is disclosed. The iridium complex takes 2-(5-phenyl-1,3,4-oxadiazoles-2-) phenol as the auxiliary ligand, and main ligand of the iridium complex molecule includes the following ligands: 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine derivatives. Such new iridium complex in the invention not only owns the high luminous efficiency, stable chemical property, easy sublimation purification and other advantages, but also has good device performance.

Claims

1. An iridium complex including two main ligands, and one 2-(5-phenyl-1,3,4-oxadiazole-2-) phenol auxiliary ligand, the main ligand being selected from any one of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine derivatives; wherein the pyridine derivatives which coordinates with iridium by C atom is: ##STR00016## the mentioned pyridine derivatives and pyridyl, pyrimidinyl, pyrazinyl, and triazinyl in different ligands have different attachment positions; arbitrarily bit of mentioned pyridyl, pyrimidyl, pyrazinyl and triazinyl are replaced by halogen or alkyl group. The quantity of substituent group on the mentioned pyridyl, the pyrimidyl and pyrazinyl and the triazinyl are 0-4, 0-3 and 0-2 respectively.

2. The iridium complex as described in claim 1, wherein the mentioned halogen is F, and the mentioned alkyl group is any one in trifluoromethyl, methyl.

3. The iridium complex as described in claim 2, wherein the 4,6-bistrifluoromethylpyridine in the main ligand has different attachment positions with pyridyl, pyrimidinyl, pyrazinyl, and triazinyl in different main ligands, taken from the 3 and 4 positions; the pyridyl, pyrimidinyl, pyrazinyl, and triazinyl are selected respectively from ##STR00017##

4. The iridium complex as described in claim 3, wherein the mentioned iridium complex includes one of the following structures: ##STR00018## ##STR00019## ##STR00020## ##STR00021## ##STR00022## ##STR00023## ##STR00024## ##STR00025## ##STR00026## ##STR00027## ##STR00028## ##STR00029## ##STR00030##

5. A manufacturing method for an iridium complex comprising the steps of: mixing two iridium dimerization bridging complexes of main ligand and 2-(5-phenyl-1,3,4-oxadiazol-2-) phenol auxiliary ligands and sodium carbonate, the mentioned main ligand being selected from one of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine derivatives; adding 2-ethoxyethanol solution for the heating reaction at 120-140° C. for 12-48 h; cooling down to the room temperature; removing the solvent by decompression and distillation; extracting and concentrating with dichloromethane; gaining the crude product of complexes by column chromatography isolation, and gaining pure iridium complex through sublimation.

6. The manufacturing method for an iridium complex as described in claim 5, wherein the molar ratio of iridium dimerization bridging complex and 2-(5-phenyl-1,3,4-oxadiazol-2-) phenol and sodium carbonate is 1:2:5.

7. An organic light-emitting diode device applying the iridium complex as described in claim 1 comprising a substrate, an anode, a hole transport layer, an organic light-emitting layer, an electron transport layer and a cathode; wherein the substrate is glass, the anode is indium tin oxide, the hole layer is made of TAPC material, the electron transport layer is made of TmPyPB material, the organic light-emitting layer comprises body material and luminous material, the body material is 1,3-bis(9H-carbazol-9-yl)benzene/mCP, the luminous material comprises the iridium complex.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0008] FIG. 1 is an electroluminescent spectra of an iridium complex GIr8-001 used in an organic light-emitting device;

[0009] FIG. 2 is an photoelectric property of the iridium complex GIr8-001 used in the organic light-emitting device; and

[0010] FIG. 3 is an photoelectric property that the iridium complex GIr8-001 used in the organic light-emitting device.

DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENT

[0011] The present disclosure will hereinafter be described in detail with reference to an exemplary embodiment. To make the technical problems to be solved, technical solutions and beneficial effects of the present disclosure more apparent, the present disclosure is described in further detail together with the figure and the embodiment. It should be understood the specific embodiment described hereby is only to explain the disclosure, not intended to limit the disclosure.

[0012] In the synthetic process of iridium complex in the invention, the Iridium trichloride, 4,6-difluoromethyl and trifluoromethyl pyridine-3 boracic acid, 4,6-difluoromethyl and trifluoromethyl pyridine-4-boracic acid, 2-Bromide pyridine derivatives, 2-Bromine pyrimidine derivatives, 2-Bromine pyrazine derivatives and 2-Bromine triazine derivatives with the similar synthesis methods. Mix iridium dimerization bridging complex containing two main ligands and the 2-(5-phenyl-1,3,4-oxadiazole-2-) phenol auxiliary ligand and sodium carbonate; The mentioned main ligands are any one of the follows: 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine the derivatives. 2-ethoxyethanol solution is added for the heating reaction at 120-140° C. for 12-48 h, then cool down to the room temperature, remove the solvent by decompression and distillation, then extract and concentrate with dichloromethane, finally gain the crude product of complexes by column chromatography isolation, and gain pure iridium complex through sublimation. Among them, the mentioned iridium dimerization bridging complex includes 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine the derivatives. The mole ratio of Iridium dimer bridging complexes, ligand and sodium carbonate is 1:2:5.

[0013] The mentioned iridium complex owns the one of the following structures:

##STR00001## ##STR00002## ##STR00003## ##STR00004## ##STR00005## ##STR00006## ##STR00007## ##STR00008## ##STR00009## ##STR00010## ##STR00011## ##STR00012## ##STR00013##

[0014] Based on one following example, the complexes GIr8-001 is used to specially describe the invention content, which would be conducted to further undertaking the invention, but isn't limited to the invention content.

[0015] Manufacturing method of complex GIr8-001

##STR00014##

[0016] 2-Bromine pyridine (26.39 mmol), 4,6-difluoromethyl and trifluoromethyl pyridine-3-boracic acid (31.66 mmol), (beta-4)-platinum (0.79 mmol) and sodium carbonate (60.00 mmol are dissolved in 100 mL butylene oxide with 65° C. reaction for 24 hours, then cool down and add water and dichloromethane. Finally, the main ligand (productivity is 52.24%) is gained from the organic horizon concentrating column by chromatography. Dissolve main ligand (13.08 mmol) and Iridium trichloride (6.23 mmol) in 15 mL 2-ethoxyethanol with mixture 130° C. reaction for 12 h, then add 2-(5-phenyl-1,3,4-oxadiazole-2-) phenol (12.46 mmol) and sodium carbonate (31.15 mmol), and continue the 130° C. reaction for 24 h. After the system cools down, add water and dichloromethane, then gain yellow solid GIr8-001 from the organic horizon concentrating column by chromatography with the productivity of 44%.

[0017] Nuclear magnetism and mass spectrometric characterization: .sup.1H NMR (500 MHz, CDCl3) δ 9.09 (d, J=5.6 Hz, 2H), 8.29 (d, J=8.4 Hz, 2H), 7.66 (t, J=8.0 Hz, 2H), 7.16 (t, J=7.4 Hz, 2H), 7.32 (t, J=6.6 Hz, 1H), 7.18-7.14 (m, 3H), 6.83 (t, J=6.5 Hz, 2H), 6.59 (d, J=8.6 Hz, 2H), 6.49 (t, J=7.4 Hz, 1H), 6.42 (s, 1H), 6.28 (s, 1H). ESI-MS: m/z 1012.10 [M]+, found: 1011.79 [M]+.

[0018] A serial of iridium complexes with green-ray were designed in this invention with each of 2-(4, 6-bistrifluoromethylpyridyl-3-) pyridine, 2-(4, 6-bistrifluoromethylpyridyl-4-) pyridine, 2-(4,6-bistrifluoromethylpyridine-3-) pyrimidine 2-(4, 6-bistrifluoromethylpyridine-4-) pyrimidine, 2-(4, 6-bistrifluoromethylpyridine-3-) tetramethypyrazine, 2-(4,6-bistrifluoromethylpyridine-4-) tetramethypyrazine and 2-(4, 6-dibtrifluoromethylpyridine-3-) triazine derivatives, 2-(4, 6-dibtrifluoromethylpyridine-4-) triazine derivatives as main ligand and 2-(5-phenyl-1, 3, 4-oxadiazol-2-) as auxiliary ligand. It reaches the purpose for control of complexes shining and electronic mobility by designing ligand or complexes structure and embellishing the simple chemical substituent group on ligand.

[0019] All mentioned Nitrogen heterocycles are the group with stronger electronic transmission, which is conductive to balancing the injection and transmission of current carrier.

[0020] The mentioned iridium complex owns higher luminous efficiency and electronic mobility. After the optimization verification, it has simple preparation method with higher productivity.

[0021] Preparation of Organic Light-Emitting Device

[0022] Based on the following example that GIr8-001 (luminescent materials) is used to prepare the organic light-emitting device, the preparation of the organic light-emitting device in the invention is described. The structure of OLEDs device includes: Substrate, anode, hole transport layer, organic light emitting layer and electron transfer layer/cathode.

[0023] The substrate for the manufacturing the device in the invention is glass, and its anode materials are indium tin oxide (ITO); Hole transport layer uses the 4,4′-Cyclohexyl 2 [N,N (4-methyl phenyl) aniline (TAPC), the material in electronic transport layer uses 3,3′-(5′-(3-(pyridine-3-buty) phenyl)-[1,1′:3′,1″-triphenyl]-3,3″-hydroxyl) bipyridine (TmPyPB) with the thickness and evaporation rate of 60 nm and 0.05 nm/s respectively; The cathode uses LiF/Al, their thicknesses are 1 nm and 100 nm respectively, and their evaporation rates are 0.01 nm/s and 0.2 nm/s respectively. Organic light emitting layer is adopted the doping structure, main body material is 1,3-bi (9H-carbazole-9-buty) benzene (mCP), and the luminescent materials selected is GIr1-001. The thickness of luminescent layer is 40 nm, the evaporation rate is 0.05 nm/s, and the GIr8-001 mass fraction is 8%.

[0024] The structure of several materials used in the invention is as follows:

##STR00015##

[0025] The green-ray complex is selected in the invention to prepare the organic light-emitting device. Please refer to FIGS. 1-3 together, in which, FIG. 1 shows the electroluminescent spectra that the iridium complex in the invention is used in organic light-emitting device, FIGS. 2-3 show photoelectric property that the iridium complex in the invention is used in organic light-emitting device. As shown in FIGS. 2 and 3, the maximum power efficiency and current efficiency of the organic electroluminescent device at question are 32.25 lm/W and 66.94 cd/A, respectively, and the maximum luminance is 33343 cd/m2 By researching the photophysical property, it's indicated that such phosphorescence iridium complex with Nitrogen Heterocycles owns higher device efficiency, and owns the practical application value in the display, lighting and other fields.

[0026] The phosphor materials in the invention could be applied in emission layer of phosphorescence OLEDs as the luminescence center. And the invention could control the emitting color and efficiency of complexes by designing ligand or complexes structure and embellishing the chemical substituent group on mentioned ligand.

[0027] It is to be understood, however, that even though numerous characteristics and advantages of the present exemplary embodiment have been set forth in the foregoing description, together with details of the structures and functions of the embodiment, the disclosure is illustrative only, and changes may be made in detail, especially in matters of shape, size, and arrangement of parts within the principles of the invention to the full extent indicated by the broad general meaning of the terms where the appended claims are expressed.